August 30, 2016 1:49 AM ET

Biotechnology

Company Overview of Symphogen A/S

Key Executives for Symphogen A/S

NameBoard RelationshipsTitleAge
Kirsten Drejer M.Sc., Ph.D.24 RelationshipsCo-Founder, Chief Executive Officer and Director60
Martin Olin Andersen EMBA, M.Sc. 10 RelationshipsChief Financial Officer and Deputy Chief Executive Officer47
Ivan D. Horak M.D., FACP19 RelationshipsChief Scientific Officer, Medical Officer, Head of Global R&D and Co-Chairman Scientific Advisory Board64
Mads Laustsen M.Sc7 RelationshipsChief Manufacturing Officer--
Gayle M. Mills M.B.ANo RelationshipsChief Business Officer61

Symphogen A/S Board Members*

NameBoard RelationshipsPrimary CompanyAge
Göran Ando M.D. 19 RelationshipsSymphogen A/S--
Kirsten Drejer M.Sc., Ph.D. 24 RelationshipsSymphogen A/S60
Ivan D. Horak M.D., FACP 19 RelationshipsSymphogen A/S64
George W. Sledge Jr., M.D. 124 RelationshipsSyndax Pharmaceuticals, Inc.64
John B. Landis Ph.D. 19 RelationshipsSymphogen A/S63
View All Board Members

Symphogen A/S Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
There is no committee data available.
*Data is at least as current as the most recent Definitive Proxy.
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary
379.7K
Bonus
264.9K
Total Short Term Compensation
476.9K
Total Value of Options
33.9M
Compensation as of Fiscal Year
Symphogen A/S CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

ProclaRx Appoints Doug Martin as New Chief Operating Officer
August 27, 2016 7:45 AM ET
OncoCyte Corporation Announces the Resignation of Dr. Michael D. West from Board of Directors
August 19, 2016 8:57 PM ET
Enumeral Biomedical Holdings, Inc. Announces the Resignation of Anhco Nguyen, Ph.D. as Vice President of Research and Development
August 19, 2016 8:30 PM ET
David A. Berry Notifies Eleven Biotherapeutics, Inc. of His Resignation as Member of the Board of Directors and the Compensation Committee
August 19, 2016 8:12 PM ET
Applied Genetic Technologies Corporation Appoints Anne M. VanLent to the Board of Directors
August 18, 2016 8:01 PM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Symphogen A/S, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.